The Radium Hospital Research Foundation (RF) is an experienced oncology focused early stage evergreen fund. Far from being a passive investor, we take an active part in our portfolio companies’ further development. Our experienced team now manages an exciting balanced portfolio of 9 biotech companies with particular strengths in immuno-oncology.
We invest in and develop companies based on the continuing flow of state-of-the-art innovations from leading research institutions.
RF has a strong collaboration with Sarsia Seed and Birk Venture. We are member of Norwegian Venture Capital Association (NVCE – Norsk Venturekapitalforening).
Privately owned companies:
Targovax AS – www.targovax.no
Ultimovacs AS – www.ultimovacs.no
Vaccibody AS – www.vaccibody.com
Nextera AS – www.nextera.no
Oncoinvent AS – www.oncoinvent.com
Biomolex AS – www.biomolex.com